相关实验视频

Updated: May 23, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

从与p38MAPK抑制剂为原料的小鼠骨髓衍生中酶体 stromal 细胞中分离出来的微和外体细胞差异调节造血干细胞功能

Pallavi Budgude^1,2, Vaijayanti Kale², Anuradha Vaidya^1,2

¹Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Pune, India.

Artificial cells, nanomedicine, and biotechnology

|March 10, 2025

概括

使用p38抑制剂对介质干细胞 (MSCs) 进行化,会产生独特的微粒细胞 (MVs) 和外体细胞 (Exos),它们可以差异调节血造干细胞 (HSC) 的扩张和功能,从而改善移植结果.

科学领域:

细胞生物学细胞生物学
干细胞生物学干细胞生物学
生物技术是生物技术.

背景情况:

介酶体 stromal 细胞 (MSCs) 分泌出影响细胞功能的微 (MVs) 和外 (Exos).
用p38抑制剂 (pMSCs) 进行MSCs的初始化,使它们复苏并增强它们支持造血干细胞 (HSC) 扩张的能力.
在HSC监管中,pMSC衍生MVs (pMVs) 和Exos (pExos) 的具体作用仍需要阐明.

研究的目的:

调查pMVs和pExos在调节HSC命运和功能的不同作用.
确定pMVs和pExos影响HSC静止和增殖的分子机制.
评估使用pMVs和pExos的复合移植策略的潜力,以提高HSC移植成功率.

主要方法:

从pMSCs中分离和描述MVs和Exos.
功能性试验评估pMVs和pExos对长期HSC (LT-HSC) 和短期HSC (ST-HSC) 的影响.
基因表达分析,功能和表型实验,以确定涉及HSC调节的分子途径.

主要成果:

pMVs促进了LT-HSC的扩张,具有自我更新和植入能力.
pExos促进了ST-HSC的扩张,具有繁殖和分化潜力.
在复合体移植中,pMVs和pExos的组合显著增强了HSC移植.
pMVs通过EGR1/Cdkn1a轴调节HSC静止,而pExos通过Nfya/Cdkn1a轴控制扩散.

结论:

来自pMSCs的pMVs和pExos不同调节HSC种群.
pMV支持LT-HSC,而pExos支持ST-HSC.
使用pMVs和pExos的复合移植策略显示,通过协同增强HSC移植,有望改善HSC移植.

关键词:

造血干细胞造血干细胞造血干细胞外基因组是外基因组的组成部分.介质细胞层层细胞.微小的微小的微小的微小的微小 p38 MAPKK 的时间.

更多相关视频

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Published on: November 16, 2018

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Published on: November 11, 2021

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...